Ozempic vs Wegovy
Same active ingredient (semaglutide). Different FDA label. Here is what that actually means.
Ozempic and Wegovy are both Novo Nordisk's semaglutide. Ozempic is FDA-approved for type 2 diabetes (max dose 2 mg); Wegovy is FDA-approved for chronic weight management (max dose 2.4 mg). Off-label use of Ozempic for weight loss has driven shortages and confusion.
Side by side.
Who picks which.
- Type 2 diabetes diagnosis with insurance coverage
- HbA1c reduction is the primary clinical goal
- Weight management is the primary clinical goal
- Want the higher 2.4 mg dose ceiling and the STEP trial weight-loss data
Same molecule. Choose the brand whose FDA label matches your clinical reason for using it. Off-label use of Ozempic for weight loss is common but contributes to diabetes-patient shortages — Wegovy or compounded semaglutide is the appropriate path for weight management.
See if I qualifyPrescription treatments require an online visit reviewed by a U.S.-licensed provider, who determines if a treatment is clinically appropriate. Compounded medications are prepared by licensed U.S. pharmacies and are not FDA-approved. Individual results vary.